AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Chemomab Therapeutics Ltd... (CMMB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.00

0.10 (5.26%)

At close: Jan 15, 2025, 10:26 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY12
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	66.83K	57.77K	34.02K	80.00K	281.91K	66.00K	51.00K	40.64K	26.25K	n/a
Gross Profit	-66.83K	-57.77K	-34.02K	-80.00K	-281.91K	-66.00K	-51.00K	-40.64K	-26.25K	n/a
Operating Income	-25.46M	-28.53M	-12.40M	-5.97M	-19.61M	-13.04M	-9.39M	-4.63M	-7.13M	24.18M
Interest Income	1.23M	351.62K	65.00	20.00K	393.00K	n/a	1K	521.00	1.03K	n/a
Pretax Income	-24.22M	-28.18M	-12.48M	-5.95M	-27.21M	-13.49M	-9.48M	-4.60M	-7.50M	24.18M
Net Income	-24.22M	-27.65M	-12.55M	-5.93M	-27.21M	-13.80M	-9.81M	-4.73M	-7.50M	24.18M
Selling & General & Admin	7.08M	11.56M	6.03M	1.29M	5.98M	5.46M	3.11M	2.25M	1.14M	5.65M
Research & Development	18.38M	16.98M	6.33M	4.68M	13.35M	7.51M	6.23M	2.34M	5.96M	15.72M
Other Expenses	n/a	n/a	n/a	749.00K	3.35M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	25.46M	28.53M	12.37M	5.97M	19.33M	12.97M	9.34M	4.59M	7.11M	21.37M
Interest Expense	n/a	353.00K	111.08K	6.00K	9.00K	n/a	5.00K	n/a	14.16K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	5.96M	5.08M	n/a	n/a	n/a	n/a
Cost & Expenses	25.46M	28.53M	12.37M	5.97M	19.61M	13.04M	9.39M	4.63M	7.13M	21.37M
Income Tax	n/a	-534.00K	77.00K	-21.00K	1.00	306.00K	323.00K	136.24K	-3	n/a
Shares Outstanding (Basic)	11.75M	11.38M	10.37M	1.85M	1.72M	631.70K	45.13K	271.67K	227.69K	50.11B
Shares Outstanding (Diluted)	11.75M	11.38M	10.37M	1.85M	1.72M	631.70K	45.13K	271.67K	227.69K	50.11B
EPS (Basic)	-2.06	-2.43	-1.21	-3.2	-15.8	-21.84	-217.31	-17.42	-32.94	0.00
EPS (Diluted)	-2.06	-2.43	-1.21	-3.2	-15.8	-21.84	-217.31	-17.42	-32.94	0.00
EBITDA	-25.39M	-28.48M	-12.33M	-5.95M	-26.92M	-13.36M	-9.50M	-4.57M	-7.46M	24.18M
Depreciation & Amortization	67.00K	57.77K	34.02K	80.00K	281.91K	66.00K	51.00K	40.64K	26.25K	n/a